For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Op-Eds
Biofueling Disorder
Would you believe that the weather in Indiana could trigger popular unrest in China? Global demand for fuel made out of food is growing…
News Release
Honk If You Support DC Car-Free Day
Newsletter
CEI Daily Update
Issues in the News 1. FINANCE The Washington, D.C. City Council votes on a measure that would limit fees on…
Newsletter
Cooler Heads Digest
News Highlights Feel Good vs Do Good on the Climate John Tierney, NYTimes, 11 September 2007 Climate Figures…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Danish scientist Bjørn Lomborg garners high-profile media attention for his new book, “Cool It:…
Blog
Vioxx Class Action Rejected in New Jersey
The New Jersey Supreme Court just rejected a nationwide class action against Merck over its drug Vioxx, recognizing that it would be inappropriate to…